- HOME
- Company Outline
- Recent Business Results
Recent Business Results
Performance (consolidated)
(¥ billion)
| 2007 | 2008 | 2009 | 2010 | 2011 | |
| Net Sales | 59.5 | 63.1 | 62.9 | 63.5 | 67.3 |
| Recurring Profit | 6.9 | 8.0 | 6.8 | 5.5 | 6.2 |
| Net Income | 4.0 | 4.5 | 4.1 | 4.0 | 3.7 |
Leading Products
May 2012
(¥ billion)
| Brand name | Active Ingredient | Indications | Launch Date |
Sales 2010 |
Sales 2011 |
Sales 2012 (estimated) |
|
| Apr.-Sep. | Annual | ||||||
| Eviprostat | herbal extracts |
prostatic hypertrophy |
Apr-67 | 6.3 | 5.9 | 2.7 | 5.2 |
| Gaslon N | irsogladine maleate |
gastric ulcer, gastritis |
Apr-89 | 4.5 | 4.9 | 2.4 | 4.9 |
| Vidaza | azacitidine | myelodysplastic syndrome |
Mar-11 | 0.3 | 4.6 | 3.2 | 7.0 |
| Hypen | etodolac | inflammation (NSAIDs) |
Sep-94 | 4.8 | 4.4 | 1.9 | 3.6 |
| Lunabell | norethisterone and ethinylestradiol |
dysmenorrhea | Jul-08 | 3.1 | 3.8 | 2.1 | 4.3 |
| Cialis | tadalafil | erectile dysfunction |
Jul-09 | 2.7 | 3.0 | 1.6 | 3.3 |
| Cephadol | difenidol hydrochloride |
vertigo | Apr-74 | 2.7 | 2.6 | 1.2 | 2.4 |
| Azunol Gargle |
sodium gualenate |
pharyngitis, tonsillitis, stomatitis,etc. |
Aug-02 | 2.5 | 2.6 | 1.2 | 2.5 |
| Bladderon | flavoxate hydrochloride |
pollakiuria | Apr-79 | 2.8 | 2.5 | 1.1 | 2.1 |
| Selectol | celiprolol hydrochloride |
hypertension, angina pectoris |
Sep-92 | 2.9 | 2.5 | 1.1 | 2.1 |
| Estracyt | estramustine phosphate |
prostatic cancer |
Apr-84 | 2.6 | 2.4 | 1.1 | 2.1 |
| Cylocide | cytarabine | solid tumor, acute leukemia |
Apr-71 | 2.7 | 2.3 | 1.2 | 2.3 |
| Baynas | ramatroban | allergic rhinitis |
Jul-06 | 2.6 | 2.2 | 0.8 | 2.3 |
| Livostin | levocabastine hydrochloride |
allergic rhinitis and conjunctivitis |
Jan-00 | 1.9 | 1.3 | 0.3 | 1.5 |
| Adcirca | tadalafil | pulmonary arterial hypertension |
Dec-09 | 0.5 | 1.1 | 0.8 | 1.8 |
| Erizas | dexamethasone cipecilate |
allergic rhinitis | Dec-09 | 0.5 | 0.7 | 0.5 | 2.0 |